Vaccine Development Services for Brain Tumors

Brain tumors, especially malignant, glioblastoma multiforme and diffuse glioma, have a very poor prognosis and are difficult to remove even with surgery, and the efficacy of radiation therapy combined with targeted therapy and chemotherapy after surgery is not very promising. Mutations in the tumor genome often result in protein changes typical of cancer, and vaccines can help the body fight the tumor by alerting the patient's immune system to these mutated proteins. Brain cancer vaccines also work by allowing the immune system to produce antibodies that can attack cancer cells.

Learn more?brain tumor vaccine development services

Category: General